Navigation Links
Merck in Medical News

Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.

PRINCETON, N.J., July 29 /PRNewswire-FirstCall/ -- Covance (NYSE: CVD ) today announced it has entered into a definitive agreement with Merck & Co., Inc. relating to the supply of genomic analysis services. Under the terms of the agreement Merck has committed to ...

Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.

NASDAQ: CRME TSX: COM VANCOUVER, July 28 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has earned a US$15 million milestone payment from its collaboration with Merck Co., Inc., through an affiliate. The milestone was triggered by th...

Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels

CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc. will terminate the research collaboration and license agreement for novel compounds targeting N-type calcium channels for the treatm...

Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.

VANCOUVER, Canada, June 11 /PRNewswire/ -- Xenon today announced a strategic alliance with Merck & Co., Inc., through an affiliate, to discover and develop novel small molecule candidates for the potential treatment of cardiovascular disease. "We are very excited to be collaborating with ...

Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective

NASDAQ: CRME TSX: COM VANCOUVER, May 19 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the waiting period under the Hart-Scott-Rodino Act for the collaboration and license agreement with Merck & Co., Inc. and a Merck affiliate for d...

Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board

CAMBRIDGE, Mass., April 7 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Eric Schadt, a leading researcher in the field of genomics-driven drug discovery, co-chair of its Scientific Advisory Board. Dr. Schadt will be leaving his position as Executive Scienti...

Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, announced today that it has successfully closed the sale of all of the Company's assets related to its follow-on biologics business to a subsidiary of Merck & Co., Inc. As a result of...

Former Merck Executive Joins Board of Clinical Information Network, Inc.

SCOTTSDALE, Ariz., March 19 /PRNewswire/ -- Clinical Information Network, Inc., the Video Detailing company, announced today that Robert J. LaBuda has joined its board of directors. Until establishing his own company in late 2008, LaBuda was the executive at Merck responsible for the successf...

The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps

New Alliance Aims to Reduce Disparities in Diabetes Prevention and Management Among Most At-Risk Populations WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- The Merck Company Foundation (Foundation), the philanthropic arm of Merck & Co., Inc., today announced the launch of The Alliance to ...

Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist

SAN DIEGO, Feb. 18 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today the initiation of a Phase 2 clinical trial of an orally administered niacin receptor agonist drug candidate being developed by Merck & Co., Inc., under its collaboration with Arena to t...

More>>

Merck in Medical Technology

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

SAN DIEGO, Feb. 24 /PRNewswire/ -- Ambrx Inc, and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by A...

Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) announced today the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine. The c...

Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.

Orchid Pharma partners with Diakron MORRIS PLAINS, N.J., Aug. 13 /PRNewswire/ -- Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I ...

MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.

MONMOUTH JUNCTION, N.J., Aug. 5 /PRNewswire/ -- MicroDose Technologies Inc. (MicroDose) today announced that the first clinical milestone in its collaboration with Merck & Co., Inc., through a Merck affiliate, has been achieved, triggering the first payment under the global license agreement f...

NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.

SOPHIA ANTIPOLIS, France, May 13 /PRNewswire-FirstCall/ -- NicOx S.A. (Eurolist: COX) today announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new n...

Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch

- Merck to Conduct Preclinical Proof-of-Principle Studies - GAITHERSBURG, Md., April 3, 2008 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI ) today announced that it has signed an agreement with Merck & Co., Inc. to conduct proof-of-principle preclinical studies evaluating th...

Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.

SILVER SPRING, Md., March 11 /PRNewswire-USNewswire/ -- In a boost to HIV prevention research, Merck & Co., Inc., has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound for use as a potential va...

Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation

Great Neck, N.Y., Jan. 18 /PRNewswire/ -- On January 17, 2008, the law firms of Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin Simes Kaiser and Gornick LLP, Bailey Perrin Bailey LLP and Weitz & Luxenberg, P.C., have filed over a Billion ($1,000,000,000) Dollar C...

Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.

SAN DIEGO, Dec. 18 /PRNewswire/ -- Ambrx Inc. today announced that it has entered into a global, strategic collaboration with Merck & Co. Inc. to develop a novel therapeutic protein with biological properties similar to Fibroblast Growth Factor 21 (FGF-21) for the treatment of type 2 diabetes ...

MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders

NEW YORK, Dec. 13 /PRNewswire-USNewswire/ --- The Michael J. Fox Foundation for Parkinson's Research has committed up to $2 million for research toward therapies to alleviate Parkinson's-related cognitive dysfunction and mood disorders. The funding is to be awarded under a new initiative, Cogn...

More>>

Merck in Medical Products

M2a-38 Acetabular Cups

Description:... Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest innovations in THR....
Company:Biomet Orthopedics, Inc

Ceracup - Ceramic Liner

Features:... Internal diameter 28 mm. The matching shell is the Batcup and the Spidercup (both IQL products) and with the Biomet merck JV Ringloc shells. Only applicable to alumina femoral heads. The Ringloc system of the Ceracup achieves two goals: liner stability and congruency betw...
Company:Biomet Orthopedics, Inc

SHP Acetabular Cup

Features:...ers available. Forms a complete system with the SHP Hip stem and the Biomet merck bone cements. Also compatible with Biomet merck hip stems....
Company:Biomet Orthopedics, Inc
Merck in Medical Dictionary

Volvulus

... which the bowel becomes twisted. ... Volvulus associated with malrotation often occurs early in life, frequently in the first year. ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and reliable animal health reference for over 45 ....

Viral arthritis

...ritis definition, symptoms, risks, treatments, side effects, how to diagnose and prevention. ... of viral arthritis include joint ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and ... of viral arthritis are followed ... ...

Uvea

...e Uvea . Ellison Bentley, DVM, Diplomate. ACVO. University of ... Posterior uvea -choroid. Iris anatomy: Anterior border, iridal stroma, ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and reliable animal health reference for over 45 ....

Uveitis

...nside of the eye inflamed. ... Uveitis is the fifth or sixth leading cause of blindness in the United States, ... Types of Uveitis ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and reliable animal health reference for over 45 ....

Transient ischemic attacks

... Transient Ischemic Attacks : Stroke (CVA): merck Manual Home Edition ^ Transient ischemic attack Mount Sinai Hospital, New York ... A TIA is a ... What is a TIA or transient ischemic...

Splenomegaly

...openia(s), normal or... Enlarged spleen — Comprehensive overview covers symptoms, causes, and treatment of splenomegaly . ... Splenomegaly . merck Manuals Online ... Splenomegaly . ... Splenomegaly is an enlargement of the spleen beyond its normal size. ... Armitage J. Approach to the pa...

Skin Diseases

...eview on the Economic Impact of Skin Diseases ... for the Three Most Common Skin Diseases , Using the Cheapest Effective Treatments ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and reliable animal health reference for over 45 ....

Shingles

...sis Prevention Resources Shingles Definition Shingles , also Find out about the causes, symptoms, and treatment of the shingles virus. From merck & Co. Learn about shingles disease and shingles vaccine. Get information about vaccine risks and benefits ... Shingles is a disease...

Seborrhea

...ea (say: seb-uh-ree-uh) is a common skin problem. ... On the body, seborrhea often occurs in the middle part of the chest, around the ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health ... Primary seborrhea is an inherited skin disorder characterized by faul...

Psychosis

... Psychosis is a loss of contact with reality, usually including false ideas about ... Treatment depends on the cause of the psychosis . ... The merck Manual of ... Psychosis often involves harboring false beliefs (delusions) ... People with psychosis often become unreasonably fearful or ... ...
Merck in Biological News

UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine

San Antonio TX -- The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio (Health Science Center) today announced an exclusive license and sponsored research agreement with Merck & Co., Inc., to develop a vaccine for chlamydia, targeting the c...

Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck

WHITEHOUSE STATION N.J., PRINCETON, N.J. and JAMAICA PLAIN, Mass., April 21, 2009 Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an...

Penn-Wistar team gains insight into HIV vaccine failure

...tar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines. The findings were published on-line July 20 in Nature Medicine . The ...

American Society for Microbiology honors Deborah T. Hung

... A 2009 American Society for Microbiology (ASM) merck Irving S. Sigal Memorial Award is being presented ...f Medicine at Harvard Medical School. Sponsored by merck Research Laboratories, the merck Irving S. Sigal Memorial Award is presented in mem...

American Society for Microbiology honors George Liu

... A 2009 American Society for Microbiology (ASM) merck Irving S. Sigal Memorial Award is being presented ... at Cedars-Sinai Medical Center/UCLA. Sponsored by merck Research Laboratories, the merck Irving S. Sigal Memorial Award is presented in mem...

American Chemical Society's Weekly PressPac -- May 20, 2009

...ing anti-malaria drugs are losing effectiveness as the parasite responsible for the disease develops resistance. The article describes how the retired merck researcher provided a long forgotten 1947 research paper detailing the company's early efforts to identify and test tropical plants that might fight m...

DNA barcoding of mosquito species deployed in bid to end elephantiasis

... endemic and treating people at risk with annual doses of a combination drug therapy (albendazole / DEC or albendazole / ivermectin, freely donated by merck and Co. and GSK respectively). The drug reduces the density of worm larvae in humans. This LF elimination strategy relies on a belief that the reg...

CHIs 5th Biomarker World Congress: Signature Event with Cutting-Edge Agenda

... Officer, Global Health Discovery, Bill & Melinda Gates Foundation Phil Hewitt, Ph.D., Head, Molecular Toxicology, Institute of Toxicology, merck KGaA Darren Hodgson, Ph.D., Biomics Advisor, Oncology Therapy Area, AstraZeneca Arthur L. Holden, Ph.D., Chairman and Chief Executive Of...

Self-digestion as a means of survival

...osomal membrane. Here, the protein waste can dock onto the autophagosome and can then be wrapped up in the membrane. Vladimir Kirkin, who is now at merck Serono in Darmstadt, is continuing these investigations with the long-term aim of developing new drugs. Dikic and his group are now concentrating on m...

Merck and AAAS announce 2009 winners of outstanding undergraduate research programs

... Fourteen colleges and universities have been selected for awards from the Merck/AAAS Undergraduate Science Research Program. Sponsored by the merck Institute for Science Education (MISE) and the American Association for the Advancement of Science (AAAS), the program awards provide up to $60,000, p...
Merck in Biological Technology

BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA

PRINCETON, N.J., July 15 /PRNewswire/ -- BioWa, Inc. announced today that it has entered into a license agreement with Merck KGaA, Darmstadt, Germany, providing the global healthcare and chemicals company with access to BioWa's POTELLIGENT((R)) Technology platform for the research, devel...

Microsoft Signs Agreement With Merck & Co. Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry

Multifaceted agreement enhances Microsoft Amalga Life Sciences to accelerate basic research and drive personalized medicine. REDMOND, Wash., June 1 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of ...

Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc.

COPENHAGEN, April 2 /PRNewswire/ -- Nuevolution A/S today announced that Merck & Co. Inc. has chosen to proceed to the second phase of the collaboration agreement announced in June 2008 to apply Nuevolution's proprietary Chemetics(R) drug discovery technology to identify novel small molecule l...

PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies

INDIANAPOLIS, Feb. 24 /PRNewswire/ -- PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) te...

Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US

Even Among Companies Doing Well, Relationships Weaken in Many Countries NEW YORK, Feb. 17 /PRNewswire/ -- New TNS Healthcare research shows that physicians in four out of the five major European countries -- the UK, Germany, Spain and Italy -- give Novartis top marks for effectively deliverin...

Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

RICHMOND, Va., Feb. 12 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a developer of follow-on biologics and biopharmaceuticals focused on niche markets with unmet medical needs, announced today that it has entered into a definitive agreement with Merck & Co., Inc. whereby Merck,...

According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists

SAN MATEO, Calif., Nov. 5 /PRNewswire/ -- In a survey of 100 infectious disease specialists following last week's ICAAC/IDSA Annual Meeting, Merck was perceived as standing out above other companies at the conference, while Tibotec Therapeutics was perceived as having the best overall image in...

Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.

Partnership to use Nuevolution's Chemetics(R) Technology for Lead Discovery COPENHAGEN, June 18 /PRNewswire/ -- Nuevolution A/S today announced that it has entered into a drug discovery collaboration with Merck & Co. Inc. Nuevolution will apply its proprietary Chemetics(R) drug discovery techn...

BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance

Potsdam, Germany, April 15, 2008 / b3c newswire / - In order to enhance the worldwide launch of its innovative food safety testing systems, BIOTECON Diagnostics has formed a strategic marketing alliance with the globally operating MERCK KGaA , Darmstadt, Germany. Merck KGaA sells the food pro...

New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting

Emerging Agent GlaxoSmithKline's Rezonic Demonstrating Efficacy for Delayed Chemotherapy-Induced Nausea and Vomiting, According to a New Report from Decision Resources WALTHAM, Mass., April 9, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading researc...
Merck in Biological Products

Benzonase from Sigma-Aldrich

Description:... Benzonase is a trademark of merck KGaA. Physical form: Solution in 50% glycerol containing 20 mM Tris HCl, pH 8.0, 2 mM MgCl 2 , and 20 mM NaCl Preparation Unit Definition: One unit wi...
Company:Sigma-Aldrich
Merck in Biological Dictionary

Teat

...reveal the quality of herd management; correctness of the ... Teat Club International (TCI) is a group of researchers, veterinarians, and ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and ... Teat obstructions are usually ... C...

Single-gene disorder

...ene disorder . 1.1 Autosomal dominant. 1.2 Autosomal recessive. 1.3 X-linked dominant ... Inheritance of Single Gene Defects - From the The merck Manual of Diagnosis and Therapy. ... See hereditary hemochromatosis disorder and gene profiles for more ... Monogenic disorder . A disorder...

Pinna

... abnormalities are found by a health care provider during ... To determine if the pinna is abnormal, the doctor will conduct a series of ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and reliable animal health reference for over ...

Phagocytes

...tbook of Bacteriology contains 46 chapters on bacteria including structure-function, growth, metabolism, ... Survival inside phagocytes ... The merck Veterinary Manual (MVM) has served veterinarians and other animal health professionals as a concise and ... Mononuclear phagocytes arise primarily...
Other Tags
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... illnesses can receive effective, less expensive care from a clinic ... a team of dedicated health care professionals, a new study ... and need either hospitalization or a trip to the emergency ... clinic at the University of Texas in Houston versus usual ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 ... "fountain of youth" drug that can delay the effects of ... study suggests. Seniors received a significant boost to their ... signaling pathway linked to aging and immune function, researchers with ... medication, a version of the drug rapamycin, improved the seniors, ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
(Date:12/22/2014)... -- NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the growing mobile commerce market, announces it has ... Robbins for the 2015 International CES debut of ... Apollo Robbins will be at the NXT-ID booth ... of his famous theft techniques to visiting media and ...
(Date:12/22/2014)...  The 2014 Holiday Season may be the ... Market Intelligence reports that the long anticipated floodgates ... forecasts that intensifying demand for smart phones, tablets, ... drive a global market of 2.5 billion users ... According to Maxine Most ...
(Date:12/19/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ... Market Monitor: North America Perimeter Security Systems Market" ... http://photos.prnewswire.com/prnh/20130307/600769 The North American perimeter security ... 3.6% from 2014 to 2019. Although the U.S. market ... Canada is expected to grow at a ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
Other Contents